57 related articles for article (PubMed ID: 38590639)
21. IL-27 attenuates airway inflammation and epithelial-mesenchymal transition in allergic asthmatic mice possibly via the RhoA/ROCK signalling pathway.
Huang C; Sun Y; Liu N; Zhang Z; Wang X; Lu D; Zhou L; Zhang C
Eur Cytokine Netw; 2022 Mar; 33(1):13-24. PubMed ID: 36102857
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory and immunoregulatory effects of icariin and icaritin.
Bi Z; Zhang W; Yan X
Biomed Pharmacother; 2022 Jul; 151():113180. PubMed ID: 35676785
[TBL] [Abstract][Full Text] [Related]
23. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes.
Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
Eur Respir J; 2022 Jan; 59(1):. PubMed ID: 34667060
[TBL] [Abstract][Full Text] [Related]
24. Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4
Huang M; Wu J; Dong J
Pharm Biol; 2021 Dec; 59(1):1216-1232. PubMed ID: 34493162
[TBL] [Abstract][Full Text] [Related]
25. Corticosteroid resistance in asthma: Cellular and molecular mechanisms.
Caramori G; Nucera F; Mumby S; Lo Bello F; Adcock IM
Mol Aspects Med; 2022 Jun; 85():100969. PubMed ID: 34090658
[TBL] [Abstract][Full Text] [Related]
26. Luteolin inhibits autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling and inhibiting Beclin-1-PI3KC3 complex.
Wang S; Wuniqiemu T; Tang W; Teng F; Bian Q; Yi L; Qin J; Zhu X; Wei Y; Dong J
Int Immunopharmacol; 2021 May; 94():107460. PubMed ID: 33621850
[TBL] [Abstract][Full Text] [Related]
27. Kaempferol Inhibits Zearalenone-Induced Oxidative Stress and Apoptosis via the PI3K/Akt-Mediated Nrf2 Signaling Pathway: In Vitro and In Vivo Studies.
Rajendran P; Ammar RB; Al-Saeedi FJ; Mohamed ME; ElNaggar MA; Al-Ramadan SY; Bekhet GM; Soliman AM
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379332
[TBL] [Abstract][Full Text] [Related]
28. The anti-asthmatic potential of flavonol kaempferol in an experimental model of allergic airway inflammation.
Molitorisova M; Sutovska M; Kazimierova I; Barborikova J; Joskova M; Novakova E; Franova S
Eur J Pharmacol; 2021 Jan; 891():173698. PubMed ID: 33129789
[TBL] [Abstract][Full Text] [Related]
29. What Is Asthma?
Sockrider M; Fussner L
Am J Respir Crit Care Med; 2020 Nov; 202(9):P25-P26. PubMed ID: 33124914
[No Abstract] [Full Text] [Related]
30. Formononetin Attenuates Airway Inflammation and Oxidative Stress in Murine Allergic Asthma.
Yi L; Cui J; Wang W; Tang W; Teng F; Zhu X; Qin J; Wuniqiemu T; Sun J; Wei Y; Dong J
Front Pharmacol; 2020; 11():533841. PubMed ID: 33013383
[TBL] [Abstract][Full Text] [Related]
31. Bidirectional interaction of airway epithelial remodeling and inflammation in asthma.
Banno A; Reddy AT; Lakshmi SP; Reddy RC
Clin Sci (Lond); 2020 May; 134(9):1063-1079. PubMed ID: 32369100
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the active components and mechanisms of Schisandra chinensis in the treatment of asthma based on a network pharmacology approach and experimental validation.
Lv X; Xu Z; Xu G; Li H; Wang C; Chen J; Sun J
Food Funct; 2020 Apr; 11(4):3032-3042. PubMed ID: 32186565
[TBL] [Abstract][Full Text] [Related]
33. Macrophage MSR1 promotes BMSC osteogenic differentiation and M2-like polarization by activating PI3K/AKT/GSK3β/β-catenin pathway.
Zhao SJ; Kong FQ; Jie J; Li Q; Liu H; Xu AD; Yang YQ; Jiang B; Wang DD; Zhou ZQ; Tang PY; Chen J; Wang Q; Zhou Z; Chen Q; Yin GY; Zhang HW; Fan J
Theranostics; 2020; 10(1):17-35. PubMed ID: 31903103
[TBL] [Abstract][Full Text] [Related]
34. Targeting cell signaling in allergic asthma.
Athari SS
Signal Transduct Target Ther; 2019; 4():45. PubMed ID: 31637021
[TBL] [Abstract][Full Text] [Related]
35. The Cytokines of Asthma.
Lambrecht BN; Hammad H; Fahy JV
Immunity; 2019 Apr; 50(4):975-991. PubMed ID: 30995510
[TBL] [Abstract][Full Text] [Related]
36. Biologic Treatments in Interstitial Lung Diseases.
Karampitsakos T; Vraka A; Bouros D; Liossis SN; Tzouvelekis A
Front Med (Lausanne); 2019; 6():41. PubMed ID: 30931306
[TBL] [Abstract][Full Text] [Related]
37. Protective effects and active ingredients of Salvia miltiorrhiza Bunge extracts on airway responsiveness, inflammation and remodeling in mice with ovalbumin-induced allergic asthma.
Luo J; Zhang L; Zhang X; Long Y; Zou F; Yan C; Zou W
Phytomedicine; 2019 Jan; 52():168-177. PubMed ID: 30599896
[TBL] [Abstract][Full Text] [Related]
38. Anti-allergic effects of salvianolic acid A and tanshinone IIA from Salvia miltiorrhiza determined using in vivo and in vitro experiments.
Heo JY; Im DS
Int Immunopharmacol; 2019 Feb; 67():69-77. PubMed ID: 30537633
[TBL] [Abstract][Full Text] [Related]
39. Macrophage polarization and allergic asthma.
Saradna A; Do DC; Kumar S; Fu QL; Gao P
Transl Res; 2018 Jan; 191():1-14. PubMed ID: 29066321
[TBL] [Abstract][Full Text] [Related]
40. The effect of bronchodilation and spirometry on fractional exhaled nitric oxide (FeNO50), bronchial NO flux (JawNO) and alveolar NO concentration (C
Karampitsakos T; Protopapas A; Gianoloudi M; Papadopoulos VP; Bouros D; Chatzimichael A; Paraskakis E
J Asthma; 2018 Aug; 55(8):882-889. PubMed ID: 28949783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
